Future Health Esg Corp (FHLT) Financials

$10.96

$0.00 (0.00%)

As on 15-Aug-2025 09:30EDT

Market cap

$65 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

10.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	0.68	2.41	0.19	--	--	--
Operating Profit (EBIT)	-0.68	-2.41	-0.19	--	--	--
Other Income	--	2.61	--	--	--	--
Profit before Tax	0.11	0.20	-0.18	--	--	--
Provision for Tax	0.15	0.14	-0.01	--	--	--
Profit after Tax (Net Income)	-0.05	0.06	-0.18	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	0.06	-0.22	--	--	--

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-0.21	6.94	193.51	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.00	9.00	9.00	--	--	--
Current Liabilities	8.44	1.32	0.12	--	--	--
Total Liabilities	17.23	17.26	202.63	--	--	--

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	17.10	16.33	201.08	--	--	--
Current Assets	0.13	0.93	1.55	--	--	--
Total Assets	17.23	17.26	202.63	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	-8.31	-0.39	1.43	--	--	--

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-0.72	-1.26	-0.24	--	--	--
Cash Flow from Investing Activities	--	187.27	-241.20	--	--	--
Cash from Financing Activities	--	-186.63	202.69	--	--	--
Net Cash Inflow / Outflow	--	-0.61	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.01	0.00	-0.02	--	--	--
Cash EPS ($)	-0.01	0.00	-0.02	--	--	--
Adjusted Book Value ($)	--	0.28	22.25	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.11	-0.05	-0.03	--	--	--
Free Cash Flow per Share ($)	-0.11	-0.05	-0.03	--	--	--

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-1.44	0.06	--	--	--	--
ROE (%)	-1.44	0.06	--	--	--	--
ROA (%)	-0.28	0.05	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	2.29	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	43.60	-1,142.69	--	--	--	--
Net Profit Growth (%)	-180.97	133.04	--	--	--	--
EPS Growth (%)	-4.07	1.12	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-1,451.83	4,212.96	-468.41	--	--	--
Price / Book Value	-332.34	36.29	0.44	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-103.37	-50.14	-445.65	--	--	--
Close Price ($)	10.67	10.10	9.75	--	--	--
High Price ($)	11.35	10.90	9.90	--	--	--
Low Price ($)	9.75	9.75	9.75	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.02	0.70	12.56	--	--	--
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	-232.97	-30.30	--	--	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--